APA (7th ed.) Citation

Fralick, M., Colacci, M., Thiruchelvam, D., Gomes, T., & Redelmeier, D. A. (2021). Sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of heart failure: A nationwide cohort study of older adults with diabetes mellitus. Diabetes, Obesity & Metabolism, 23(4), 950. https://doi.org/10.1111/dom.14300

Chicago Style (17th ed.) Citation

Fralick, Michael, Michael Colacci, Deva Thiruchelvam, Tara Gomes, and Donald A. Redelmeier. "Sodium‐glucose Co‐transporter‐2 Inhibitors Versus Dipeptidyl Peptidase‐4 Inhibitors and the Risk of Heart Failure: A Nationwide Cohort Study of Older Adults with Diabetes Mellitus." Diabetes, Obesity & Metabolism 23, no. 4 (2021): 950. https://doi.org/10.1111/dom.14300.

MLA (9th ed.) Citation

Fralick, Michael, et al. "Sodium‐glucose Co‐transporter‐2 Inhibitors Versus Dipeptidyl Peptidase‐4 Inhibitors and the Risk of Heart Failure: A Nationwide Cohort Study of Older Adults with Diabetes Mellitus." Diabetes, Obesity & Metabolism, vol. 23, no. 4, 2021, p. 950, https://doi.org/10.1111/dom.14300.